Christian Amatore, Gérard Jaouen. The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif. Dalton Transactions, Royal Society of Chemistry, 2007Chemistry, , pp.5073-5081. 10.1039 The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2- The ferrocenyl compound 2-ferrocenyl-1,1-bis(4-hydroxyphenyl)-but-1-ene (3), is very cytotoxic against breast cancer cells (IC 50 = 0.44 µM against MDA-MB-231). We now report the synthesis of a new series of para-and meta-substituted mono-and di-ferrocenyl phenols
Introduction
Although the anti-cancer properties of ferrocene-containing molecules were first studied in the late 1970s, 1 systematic investigations were not carried out until Köpf-Meyer and Neuse established anti-tumour activity for ferricenium salts in 1984. 2 This work led to the proposal that ferrocenyl compounds could be activated in the cell by biooxidation, and that bothferricenium and ferrocene-(in a water soluble form) containing compounds could give rise to cytotoxic effects. 3 To this end ferrocene has been incorporated into water soluble polymers, 4 tethered to a DNA intercalator, 5 phosphino compounds, 6 vitamin B1, 7 and other biomolecules. 8 Diferrocene compounds 9 and ferrocene-bearing transition metal ligands, 10 and a variety of other small ferrocenyl molecules 11 have also been investigated for anti-cancer activity. Cytotoxic pathways involving DNA have been suggested for the activity of ferrocenyl compounds.
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Our laboratory has been studying the effects on the proliferation of breast cancer cells of ferrocenyl phenols, especially those based on the 1,1-diphenyl-but-1-ene motif. 13, 14 Some small organic phenols have been shown to possess oestrogen receptor modulating properties, 15 and, at higher concentrations, cytotoxic properties. 16 We have been trying to enhance the cytotoxicity of these types of compounds by the addition of ferrocene, which we hope will be oxidized to ferricenium within the cell. We routinely test the proliferative/antiproliferative effects of our new compounds on MCF-7 (oestrogen receptor positive) and MDA-MB-231 (oestrogen receptor negative) breast cancer cell lines, and have had varying degrees of success. The most promising compounds to date are shown in Chart 1, all of which exhibit IC 50 values at low micromolar or submicromolar concentrations for the MDA-MB-231 cell line. The MCF-7 cell line is the standard for hormone dependant breast cancers, and the proliferative/antiproliferative effects connected to the estrogenicity/antiestrogenicity of molecules at concentrations of 10 -5 -10 -7 M are primarily mediated by the oestrogen receptor alpha (ERα), a nuclear receptor present in these cells. It is known that the dimethyl amino chain of the active metabolite of the breast cancer drug tamoxifen, and also present in compound 1, interacts with ERα in such a way as to prevent would be expected to be estrogenic and proliferative on MCF-7 cells. However, compounds 2-4 have shown antiproliferative effects in both the MCF-7 (ER+, hormone dependent) and MDA-MB-231 (ER-, hormone independent) cell lines, which can be attributed only to the innate cytotoxicity of the molecule. It is important to note that 1-4 conform to a particular structural motif, where the ferrocenyl group is located on carbon 2 of the but-1-ene group, the phenol group(s) resides on carbon 1, and a conjugated -system exists between the ferrocenyl and phenol groups. It appears that this motif is directly related to the cytotoxic effects shown by these compounds. In a previous study we discovered that compounds 1-4 exhibit cyclic voltammograms characteristic of an interesting structural rearrangement due to an intramolecular electron transfer from the phenolic donor to the electrochemically generated ferricenium acceptor in basic conditions. 18 We have proposed that the final outcome of this process is the formation of a reactive quinone methide-type (QM) structure after two oneelectron oxidations and the loss of two protons. Donor-acceptor assemblies possessing a ferrocene donor have been extensively studied, especially in terms of their non-linear optical properties, 21 and structural rearrangements as a result of proton-or metal ion-coupled intramolecular electron transfer processes. 22 However, the possibility of a ferricenium moiety acting as an acceptor has only recently been explored. 23, 24 In particular, a paper by Nishihara and co-workers in Tokyo described the rearrangement of 2-(2-ferrocenylvinyl)hydroquinone to a novel allene quinonoid structure via two one-electron oxidations and intramolecular electron transfer to a ferricenium acceptor. 25 In order to test our hypothesis that QM-generation is related to the observed cancer cell death, and to further study this novel mechanism of formation, we have synthesized a number of new compounds, including those where the hydroxyl group of the phenol is in the metaposition. For example, in compound 6, the ferrocene--system-phenol motif is maintained, but it carries a m-phenol, so that a QM structure is not accessible. Compound 7 is similar to 6, with the addition of a p-phenol group; in this case we expect that the m-phenol will act as a spectator, and the p-phenol might engage in QM formation. We have also synthesized the diferrocenyl p-phenol (8) , and m-phenol (9) to evaluate the importance of the steric effect on the biological efficacy of the compounds. We here report the synthetic, electrochemical, and biochemical results for the new compounds 5-9 shown in Chart 2, and compare these results to those of previously reported compounds 2 and 3 as appropriate.
Chart 2 New compounds studied in this report.
Scheme 1

Results and discussion
Synthesis
The formation of the new compounds 5-9 was generally accomplished by a Friedel-Craft acylation of ferrocene, followed by a McMurry cross-coupling of the ferrocenyl ketone with the appropriate benzophenone. Thus, to synthesize compounds 8 and 9, we first prepared the known ketone 10 26 (yield 62%) and the new ketone 11 (yield 82%) by a Friedel-Craft reaction of the corresponding acyl chlorides with ferrocene, as shown in Scheme 1. The ketones were demethyled with boron tribromide in dichloromethane to give the phenolic compounds 12 and 13 with yields of 74% and 76%, respectively. The yield for the formation of 12 using boron tribromide was higher than the previously reported demethylation of 10 with aluminium trichloride (32%), 26 but the reaction time was longer (unoptimized 12 h vs. 1.25 h). The
McMurry reaction of these ketones with propionyl ferrocene 27 gave the cross-coupled diferrocenyl compounds 8 and 9 with a yield of 39% for each, Scheme 2.
Scheme 2
In the same manner, the McMurry reaction of propionyl ferrocene with dibenzophenone gave compound 5 with a yield of 25%, Scheme 3. This compound was impossible to separate by silica gel column chromatography from the two homo-coupled compounds, due to the similar (low) polarities of these compounds lacking any phenol group. Compound 5 was directly isolated by preparative HPLC of the crude mixture.
Scheme 3
The mono-ferrocenyl compounds 6 and 7 were synthesized from propionyl ferrocene by a
McMurry reaction using the corresponding phenolic ketones (commercially available for 6, and known from the literature for 7 28, 29 ) to give a mixture of Z and E isomers in an approximately 1 : 1 ratio.
Compounds 6 and 7 were purified on a silica gel column with dichloromethane or a dichloromethane-acetone solution as the eluent, and then were re-purified via HPLC. Z and E isomers of compounds 6 and 7 were impossible to separate, while isomers of compounds 8 and 9 were partially separated but rapidly (within a few hours) isomerised to give a 1 : 1 mixture of Z and E isomers.
Cyclic voltammetry.
Compounds 5-9 were studied by cyclic voltammetry in methanol and methanol-pyridine solutions. In methanolic solutions, all of the compounds gave rise to the expected reversible ferrocene/ferricenium redox waves, with 5, 6, and 7 giving rise to one wave, and compounds 8 and 9 displaying 2 one-electron waves. In terms of the interaction of the electrochemically generated cations with the added pyridine, the compounds can be divided into two categories. For compounds 5, 6 and 9, which do not possess p-phenols, no significant difference in the electrochemical behaviour was observed upon the addition of pyridine, Fig. 1a ,b. Conversely, for those compounds carrying a p-phenol, 7 and 8, the addition of pyridine altered the CV substantially, especially in view of the reversibility of the ferrocene redox couple and the emergence of a new peak slightly higher in potential than the ferrocene oxidation. We have previously observed this electrochemical behaviour for compounds 1-4, and have attributed it to an intramolecular electron transfer from the organic skeleton to the ferricenium moiety coupled with deprotonation of the phenol by pyridine, eventually resulting in a QM structure. 18 While the electrochemical behaviour of compound 7 is similar to that of compounds 1-4, that of 8 is complicated by the presence of a second ferrocenyl group. The voltammetry of 8 in the presence and absence of pyridine shows that the intramolecular electron transfer leading ultimately to the quinone methide formation occurs at the level of the first oxidation wave.
Since the ferricinium group attached to the C1 carbon atom of the central double-bond (see Scheme 4) cannot be conjugated directly to the phenol moiety, one must conclude that the intramolecular phenol oxidation occurs via the C2 ferricinium. Yet since both ferrocene units
give rise to a significant electron transfer interaction, one cannot strictly differentiate between the two under electrochemical conditions. Nevertheless, this suggests that the C1 ferrocene moiety is oxidized after the electron transfer to the C2 ferricenium moiety and rearrangement to the quinonoid, as shown in Scheme 4. 
Scheme 4
Thus, the electronic environment around the C1 ferrocene is expected to be substantially changed when it is finally oxidized. This is confirmed by the large anodic shift of its oxidation potential in MeOH-py compared to that in MeOH (0.703 vs. 0.504 V, respectively). The influence of nearby quinonoids on the destabilization of the ferricenium cation has been previously observed, and has been attributed to partial electron donation from the ferrocene to the quinonoid moiety.
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Chart 3 Electron delocalization on a) p-phenol and b) m-phenol.
We asked ourselves why only the compounds possessing a p-phenol engaged in electron transfer, given the ostensible similarities in molecular and electronic structure between these compounds. We have previously shown in these types of compounds that in the initial cation the radical is localized on the ferricenium group, and that there is little electronic delocalization with the phenol group prior to deprotonation. 18 This is supported by the comparison of the ferrocene oxidation potentials in MeOH for 2 (0.397 V), 5 (0.421 V), and 6
(0.403 V), which show little difference, and hence little stabilization of the radical by the phenol group. The answer may be found instead in considering the stability of the neutral radical species which is generated after electron transfer and deprotonation. By drawing the canonical structures contributing to the delocalization of the radical, Chart 3, we can see that the p-phenol is able to delocalize the radical onto the C1,C2-alkene, while the radical in the m-phenol can only be delocalized over the phenol itself. Thus, complexes with a parasubstituted phenol benefit from greater resonance stabilization and are therefore energetically more accessible intermediates than their m-phenol analogues.
Biochemistry
RBA and lipophilicity values. The affinities for the oestrogen receptor of the newly synthesized complexes were measured on the two isoforms of the oestrogen receptor, ERα and ERβ, and are reported as relative binding affinity (RBA) values in Table 2 . All the compounds were recognized by both forms of the ER but the RBA values are quite different ranging from high (about 5%) to low values (less than 1%). In the mono-ferrocenyl series the change of the OH substituent from the para-to the meta-position induced only a slight decrease of the RBA value for the alpha form of the estrogen receptor (4.6% versus 3.6% for the monophenols, 9.6% versus 5.4% for the diphenols). On the contrary, the presence of an m-OH substituent dramatically decreased the affinity of the complexes for the beta form of the oestrogen receptor with an RBA ratio ERβ/ERβ of 21 for the monophenols 2 and 6, and 6.8
for the diphenols 3 and 7. Quite surprisingly, the diphenyl complex 5, i.e. the compound with no OH, has a non-zero RBA value of 0.9%. A similar RBA value (0.8%) was previously reported for the corresponding organic molecule, 1,1,2-triphenylbut-1-ene. 32 Finally, the RBA values found for the di-ferrocenyl derivatives are quite low for both forms of the oestrogen receptor. This is probably due to the presence of the two ferrocenyl units which are bulkier than a phenyl substituent. Regarding the log P o/w values, the change of the OH group from the para-to the meta-position plays no role, and, as expected, the complexes with no hydroxyl groups or with two ferrocenyl substituents are more hydrophobic with log P o/w values around 6.4.
Effect of the compounds on the growth of breast cancer cells.
The effect of these complexes at a concentration of 1×10 -6 M was studied on hormoneindependent (MDA-MB-231) and hormone-dependent (MCF-7) breast cancer cells and the results are displayed in Fig. 2 versus 2 and 7 versus 3 being respectively 2.4 and 2.3). The presence of a second ferrocenyl unit decreases the cytotoxicity of the complexes (IC 50 of 2.8 µM for 8 and 1.13 µM for 2; 3.5 µM for 9 and 2.7 µM for 6); here also the complex with a m-OH group is less cytotoxic than the one with a p-OH. Finally, as expected, estradiol has no effect on these cells with no ERα.
On the contrary, the effect observed on hormone-dependent breast cancer cells is the result of the estrogenic (proliferative) effect expected for these compounds that all show an affinity for the alpha form of the ER minus its cytotoxic component observed on the hormoneindependent cancer cells. At a concentration of 1 µM and in a medium without phenol red, which is best suited to the expression of the estrogenic component of a molecule, only the most cytotoxic complexes 2 and 3 are able to reverse the strong estrogenic effect shown by estradiol. As expected complexes 5 and 6 which are the less cytotoxic on the MDA-MB-231 cells show a clear proliferative effect.
Experimental
General remarks
The synthesis of all compounds was performed under an argon atmosphere, using standard General procedure for formation of compounds 5, 6, 7, 8, 9.
Titanium tetrachloride (3.6 mL, 33 mmol) was added dropwise to a suspension of zinc powder (4 g, 61 mmol) in 80 mL of dry THF at 0 °C. The mixture was heated at reflux for 2 h. A second solution was prepared by dissolving propionyl ferrocene (2.42 g, 10 mmol) and the corresponding ketones (10 mmol) in 50 ml of dry THF. This latter solution was added dropwise to the first solution and then the reflux was continued for 2 h. After cooling to room temperature, the mixture was stirred with water and dichloromethane. The mixture was acidified with diluted hydrochloric acid until the dark colour disappeared and was decanted.
The aqueous layer was extracted with dichloromethane and the combination of organic layers was dried over magnesium sulfate. After concentration under reduced pressure, the crude product was chromatographed on a silica gel column with dichloromethane or a solution of dichloromethane-acetone 95 : 5 as the eluent (5 excepted 
2-Ferrocenyl-1-(3-hydroxyphenyl)-1-(4-hydroxyphenyl)-but-1-ene, 7.
The reaction was performed with 2.14 g (10 mmol) of the known 3,4'-dihydroxybenzophenone. 29 The 
Biochemical experiments Materials
Stock solutions (1 × 10 -3 M) of the ferrocenyl complexes 2, 3, and 5-9 to be tested were prepared in DMSO and were kept at 4 °C in the dark; under these conditions they are stable at least two months. Serial dilutions in DMSO were prepared just prior to use. A stock solution 
Conclusions
Our results show that the presence of a p-phenol has a significant influence on both the electrochemistry and on the biological efficacy of these ferrocenyl phenol compounds, supporting our hypothesis that oxidative activation to a QM structure may be a key to their biological activity. Compounds 5 and 6 which do not possess a p-phenol also did not show intramolecular electron transfer and rearrangement to a QM structure in the electrochemical experiments, as expected. Compound 5, lacking any kind of phenolic group, showed no appreciable cytotoxicity, while 6, possessing only a m-phenol, was much less efficacious than its para-substituted analogue 2. Similarly, compound 7, carrying one m-and one p-phenol did not show nearly as strong an activity as that of 3, which possesses two p-phenols. In fact, the biological activity of 7 is much closer to that of 2 (with IC 50 values of 1.13 vs. 1.03 µM, respectively) than that of 3 (0.44 µM).
The diferrocenyl compounds 8 and 9 follow the same trend, with higher biological activity observed for p-phenol 8, than m-phenol 9. As expected, electron transfer from the phenol to the ferricenium moiety is only electrochemically observed for compound 8. However, the activity of these compounds cannot be solely attributed to their electronic and structural rearrangements. There also exists the steric effect of the additional ferrocene group, which has a negative effect on the biological activity of 8 and 9. Whether carrying a p-or m-phenol, the diferrocenyl compounds are less efficacious than their mono-ferrocenyl analogues 2 and 6.
Although each of the compounds carrying a p-phenol behaves similarly from an electrochemical perspective, the steric effect suggests that the QMs are formed, or react, via one or several specific biological pathways. For example, QMs are alkylating agents which can react with O-, N-, or S-nucleophiles, especially glutathione, via a Michael 1,4-addition. 35 The depletion of glutathione can then lead to the alkylation of proteins by an excess of quinone. Alternatively, quinonoids are known to undergo redox cycling in cells resulting in the production of ROS, via such enzymes as NADPH:cytochrome P450 reductase, NADPH:cytochrome b 5 reductase, NADPH:ubiquinone oxidoreductase, and NAD(P)H:quinone oxidoreductase, among others, 36 and iron-containing compounds are known to produce ROS via the Fenton reaction and H 2 O 2 . We are currently investigating the ROS production of these types of compounds, and we hope that future use of specific ROS probes and enzyme-inhibitors will allow us to begin to unravel the metabolic fate of this new class of cytotoxic ferrocenyl phenolic compounds.
